Overview

QUILT-3.091 NANT Chordoma Vaccine vs Radiation in Subjects With Unresectable Chordoma.

Status:
Withdrawn
Trial end date:
2022-08-30
Target enrollment:
Participant gender:
Summary
QUILT 3.091 Chordoma Vaccine: Phase 1B/2 NANT Chordoma Vaccine vs Radiation in Subjects with Unresectable Chordoma.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
ImmunityBio, Inc.
NantKwest, Inc.
Treatments:
Avelumab
Cetuximab
Cyclophosphamide
Doxorubicin
Vaccines